India Medical Devices Market By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Medical Devices Market is projected to grow from USD 16.17 Billion in 2024 to USD 22.30 Billion by 2030 at a 5.46% CAGR. Medical devices are instruments, machines, apparatuses, implants, or similar devices designed to diagnose, monitor, treat, or prevent diseases, injuries, or other medical conditions. They play a vital role in healthcare, aiding healthcare professionals in diagnosing and treating patients and assisting individuals in managing their health. Medical devices can vary greatly in complexity, purpose, and application.  

India's rising healthcare expenditure, both by the government and private sector, has been a major driver. The government's initiatives, such as the Ayushman Bharat program, have significantly increased healthcare funding, leading to greater demand for medical devices. India has become a preferred destination for medical tourism due to the availability of high-quality healthcare services at a lower cost. Medical tourists require advanced medical devices and treatments, boosting market growth.

For instance, in May 2025, Fortis Mohali introduced advanced clot retrieval devices for treating vascular-related disorders. These cutting-edge technologies significantly reduced the risk of bleeding, improved patient safety, and enabled faster recovery. The hospital’s adoption of these devices marked a significant advancement in minimally invasive treatment options, offering more effective outcomes for patients with critical vascular conditions. 

Expanding healthcare services in rural areas is a priority, and this requires equipping healthcare facilities with medical devices suitable for remote and underserved regions. Advances in medical technology, including point-of-care testing, minimally invasive surgery, and wearable devices, have driven the adoption of innovative medical devices in the Indian market. Increasing patient awareness about healthcare options and the benefits of early diagnosis has driven demand for diagnostic and monitoring devices. The presence of multinational medical device companies in India has not only increased competition but also brought advanced technologies and products to the market.

Key Market Drivers

Innovations in Technology

Technological innovation is reshaping India’s medical devices landscape by making diagnosis, monitoring, and intervention more portable, connected, and precise, which supports faster care delivery across hospitals, ambulances, clinics, and homes. Point of care use is expanding as GE HealthCare’s Vscan Air is designed as a wireless handheld ultrasound with dual probe capability for whole body scanning, allowing clinicians to carry imaging in the palm of the hand and use it during rapid bedside assessments rather than depending only on fixed radiology setups.

At the same time, remote monitoring is becoming more practical because Philips says its patient monitoring portfolio spans bedside and transport monitors, central monitoring systems, clinician mobile apps, and remote patient monitoring devices that stream live interoperable data for near real time decision making. AI is also strengthening diagnostic performance in advanced imaging, with Siemens Healthineers stating that it has more than 80 AI powered offerings on the market and over 1,100 patent families related to machine learning, reflecting how automation is being embedded into radiology and molecular imaging workflows.

For instance, Siemens says its Lesion Scout with Auto ID on the Biograph PET CT platform can assess an entire patient dataset within 10 seconds with 92 percent accuracy, showing how major medtech companies are bringing measurable gains in speed, precision, and personalized decision support that directly reinforce innovation momentum in the India medical devices market.

Rural Healthcare Expansion

Rural healthcare expansion is becoming an important demand driver for medical devices in India because the National Rural Health Mission was created to provide accessible, affordable, and quality healthcare to rural populations, especially vulnerable groups, while the government’s eSanjeevani telemedicine model is designed to support all 1.5 lakh Ayushman Bharat Health and Wellness Centres and has already been described by the Health Ministry as making an impact in smaller towns and rural areas.

This widening care network is increasing the need for portable diagnostic, monitoring, maternal care, and emergency response equipment, since official telemedicine guidelines note persistent shortages of doctors and specialists in rural areas and explicitly position digital health tools as a way to bridge gaps in continuity of care, prescribing, and service delivery closer to the community.

Manufacturers are aligning with this shift through compact point of care technologies, with GE HealthCare’s India platform highlighting Vscan Air as a wireless handheld ultrasound that combines two transducers in one probe and enables whole body scanning at the point of care, making it more practical for frontline use outside conventional imaging departments. In January 2025, CDSCO also clarified to Customs that refurbished medical devices cannot be imported for sale or distribution because the Medical Devices Rules 2017 contain no specific provision for regulating them, reinforcing patient safety expectations and strengthening the case for higher quality domestic manufacturing.

For instance, Molbio states that 451 Truenat machines were launched across Uttar Pradesh and that having a Truenat machine in every district and hospital significantly enhanced timely diagnostics, showing how Indian companies are already scaling indigenous point of care devices that fit the realities of rural screening, infectious disease management, and decentralized healthcare delivery.

Increasing Patient Awareness

India’s evolving manufacturing and trade initiatives, including Make in India, the PLI scheme, the National Medical Devices Policy 2023, and CDSCO’s global alignment, are strengthening domestic medical device production while increasing patient awareness. Greater access to affordable, high-quality technologies empowers patients to make informed healthcare decisions and actively participate in preventive care through regular check-ups and screenings driving demand for diagnostic and monitoring devices.

Awareness of early disease detection encourages higher utilization of imaging and diagnostic equipment. Patients increasingly adopt wearables and home monitoring tools to track vital signs, manage chronic conditions, and seek timely intervention. Informed individuals engage more effectively in self-care, using devices such as glucometers, inhalers, insulin pumps, and CPAP machines, while adherence to prescribed therapies further supports device adoption.

Educated patients also participate in shared decision-making, influencing device selection and treatment pathways. Growing familiarity with telemedicine promotes virtual consultations and remote monitoring, increasing demand for connected medical technologies. Tech-savvy consumers invest in fitness trackers, smart scales, and mobile health apps, expanding the consumer device segment. Participation in clinical trials introduces patients to advanced monitoring tools, aiding innovation. Moreover, informed patients advocate for better access to modern healthcare infrastructure and willingly share health data to enable personalized medicine—collectively accelerating growth in the India Medical Devices Market.

Download Free Sample Report

Key Market Challenges

Price Sensitivity

Price sensitivity is a defining feature of medical device adoption in India because public procurement limits and household affordability both push hospitals and clinicians to select products that deliver essential clinical performance at the lowest sustainable cost, a reality reinforced by the fact that AB PMJAY provides cashless hospitalization cover of up to Rs 5 lakh per family per year for secondary and tertiary care.

This cost discipline matters at very large scale, since PIB reported that as of October 1 2025 more than 42 crore Ayushman cards had been created and over 33,000 hospitals were empanelled under AB PMJAY, making device pricing a system wide issue across a massive treatment network. Government regulation clearly reflects this affordability focus, with NPPA revising the ceiling prices for coronary stents effective April 1 2025 to Rs 10,692.69 for bare metal stents and Rs 38,933.14 for drug eluting stents including bioresorbable vascular scaffolds. The same logic extends to orthopaedics, where NPPA continued ceiling prices for knee implants at Rs 51,563 for a primary knee replacement system and Rs 83,547 for a revision knee replacement system, reinforcing price led purchasing decisions in hospitals and among patients.

For instance, Poly Medicure reported that its domestic revenue grew 19 percent in FY2025 and that its renal division domestic revenue rose 60 percent, showing how manufacturers that scale competitively priced, locally relevant product lines can fit more effectively into India’s affordability driven medical device environment.

Quality Control and Counterfeit Products

Substandard or counterfeit medical devices can pose serious risks to patient safety. The use of such products can lead to incorrect diagnoses, treatment complications, and adverse health outcomes. In the past, the regulatory environment in India for medical devices was less stringent, allowing for substandard and counterfeit products to enter the market. While efforts have been made to strengthen regulations, challenges in enforcement persist. The monitoring and surveillance of medical devices post-market can be inadequate.

This means that substandard or counterfeit products may go undetected until adverse events occur. India relies on imported medical devices, which can be susceptible to counterfeit products, especially when imported from regions with less stringent quality control standards. The Indian government's push for local manufacturing, as part of the "Make in India" and "Atmanirbhar Bharat" initiatives, aims to reduce dependence on imports. However, this also necessitates a focus on maintaining quality standards in locally manufactured devices.

Key Market Trends

Adoption of Digital Health Solutions

Telemedicine platforms and telehealth services have seen substantial growth in India since the COVID-19 period, enabling remote consultations that reduce the need for in-person visits and improve access, especially where specialist availability is limited. For instance, the Ministry of Health and Family Welfare’s national telemedicine service eSanjeevani had served over 36 crore patients through teleconsultations as of 6 April 2025, illustrating how remote care has scaled for routine OPD needs as well as follow-ups.

This expansion is being reinforced by the Ayushman Bharat Digital Mission infrastructure, with more than 73 crore Ayushman Bharat Health Accounts created as of 20 January 2025 and more than 5 lakh health professionals registered, which helps standardize digital identity and provider availability for online-first care pathways. Electronic health records and health information exchange are also gaining momentum through ABDM-linked records, with PIB reporting over 67 crore ABHA created and more than 42 crore health records linked, along with over 1.3 lakh ABDM-enabled facilities including more than 17,000 private facilities, enabling more consistent digital capture and sharing of patient data for coordinated care.

In parallel, India’s Unified Health Interface and other ABDM building blocks are expanding interoperability, with PIB noting that over 236 private entities are integrated into the ABDM ecosystem, which supports app-based services such as digital OPD registration, digital prescriptions, and lab reports, and reduces test duplication by improving verified data exchange across providers. As these connected records and digital workflows mature, they also strengthen the foundation for remote monitoring, consumer wearables, and AI and machine learning use cases such as medical image analysis and risk prediction by making longitudinal patient data more consistently available for clinical decision support.

Segmental Insights

Type Insights

In 2024, the India Medical Devices Market largest share was held by Diagnostic Imaging Equipment segment and is predicted to continue expanding over the coming years. The prevalence of various diseases, including cardiovascular diseases, cancer, and orthopaedic conditions, has been on the rise in India. Diagnostic imaging equipment plays a critical role in the early detection and diagnosis of these diseases, driving demand for these devices. Diagnostic imaging equipment, such as MRI machines, CT scanners, and X-ray machines, are essential for providing advanced healthcare services. Major hospitals and diagnostic centres rely on these devices for accurate and timely diagnoses, making them a central component of the healthcare infrastructure. India has been investing in expanding its healthcare infrastructure, including the establishment of new hospitals, diagnostic centres, and clinics.

These facilities often prioritize equipping themselves with modern diagnostic imaging equipment to offer comprehensive services. Increasing health insurance coverage in India has made advanced diagnostic procedures more accessible to a larger portion of the population. This has led to an increased utilization of diagnostic imaging equipment in healthcare facilities. Advances in diagnostic imaging technology have made these devices more precise and accessible. Innovations in equipment design, imaging software, and data analysis have improved the accuracy of diagnoses. There is a growing awareness of preventive healthcare in India. Screening and early detection of diseases have become a focal point for both healthcare providers and patients, leading to greater demand for diagnostic imaging equipment.

Download Free Sample Report

Regional Insights

The North India region dominated the India Medical Devices Market in 2024, led by Delhi NCR’s concentration of tertiary hospitals, teaching institutions, and diagnostic hubs that tend to adopt advanced devices earlier and at higher volumes. For instance, Delhi’s Economic Survey reported that total hospital beds in the national capital increased from 48,096 in 2014-15 to 57,194 in the latest fiscal cited in the report, and also noted a wide care footprint comprising 88 hospitals and 17 medical colleges, which typically translates into sustained demand for imaging, critical-care, surgical, and lab devices across public and private procurement.

North India’s large urban patient catchments and higher treatment intensity around major referral centers further strengthen device utilization, because higher inpatient and procedure loads require continuous replenishment of consumables and upgrading of capital equipment. India’s inbound patient flows also reinforce Delhi NCR’s hub position, with the Ministry of Tourism’s India Tourism Data Compendium noting that air travel accounted for 79.4 percent of foreign tourist arrivals and 57.2 percent landed in Delhi and Mumbai, while Delhi recorded 1.83 million foreign tourist visits in 2023. Medical tourism adds another demand layer for high-end diagnostics and surgical systems, as government-reported foreign tourist arrivals for medical purposes reached 6,44,387 in 2024 and 1,31,856 during January to April 2025.

Recent Developments

• In October 2025, Medtronic launched the Valleylab FT10 Electrosurgical Generator and the FT10 Vessel Sealing Generator in India, expanding the company’s advanced energy-based surgical device portfolio in the market. The company said the systems use TissueFect sensing technology to automatically adjust energy delivery based on tissue type, which is intended to improve precision, safety, and efficiency during surgery. This was a significant product launch for India’s medical devices sector because it brought higher-end operating-room technology into the country at a time when hospitals are increasingly looking for tools that improve workflow as well as clinical outcomes.
• In June 2025, Eli Lilly said India’s drug regulator had approved the launch of pre-filled injector pens for its blockbuster obesity treatment Mounjaro, marking a notable device-linked rollout in the country’s broader medical technology market. Reuters reported that the pen launch was aimed at making the therapy more competitive against rival injectable products and reflected growing demand in India for self-administered delivery devices alongside specialty medicines. This mattered for the Indian medical devices landscape because pre-filled pens sit at the intersection of pharmaceuticals and device engineering, and their expansion usually supports growth in local cold-chain handling, hospital adoption, and patient-facing delivery technology.
• In January 2026, Polymatech Electronics announced the CDSCO registration and start of domestic manufacturing for its Vein Finder devices, describing them as the first fully regulated, indigenously developed products of their kind in India. The company said the near-infrared device was designed to help clinicians visualize veins more effectively, reduce repeated puncture attempts, and improve patient comfort, while also adding digital features and maintaining end-to-end domestic manufacturing capability. This counted as a breakthrough innovation for India’s medical devices sector because it combined regulatory compliance, local manufacturing, and indigenous component technology in a clinically useful point-of-care device rather than a low-complexity consumable.

Key Market Players

• Wipro GE Healthcare Pvt. Ltd.
• Mindray Medical India Pvt Ltd
• Siemens India
• Philips India Ltd
• Hitachi Medical Systems India
• Shimadzu India
• Fujifilm India Pvt. Ltd, India
• Medtronic Pvt Ltd
• Johnson & Johnson Medical India Limited
• Abbott India Limited
• Becton, Dickinson Private Limited
• Roche Diagnostics India limited.
• Alcon Laboratories (India) Private Limited
• Carl Zeiss India Private Limited
• Canon Medical India

Report Scope:

In this report, the India Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

•  Medical Devices Market, By Type:

o   Cardiovascular Devices

o   Diagnostic Imaging Equipment

o   In-vitro Diagnostic Devices

o   Ophthalmic Devices

o   Diabetes Care Devices

o   Dental Care Devices

o   Surgical Equipment

o   Patient Monitoring Devices

o   Orthopedic Devices

o   Nephrology & Urology Devices

o   ENT Devices

o   Anesthesia & Respiratory Devices

o   Neurology Devices

o   Mobility-Aid Devices

o   Others

• Medical Devices Market, By End-User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Others

• Medical Devices Market, By region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Medical Devices Market.

Available Customizations:

India Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Medical Devices  Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]